Merck Seeks Oxytrol Switch For Women As First Overactive Bladder OTC
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck will present to FDA’s Nonprescription Drugs Advisory Committee Nov. 9 in support of switching Watson’s Oxytrol as a female-specific OTC.